BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Chen C, Lai C, Lee K, Huang S, Dai Y, Chen M. Risk of second primary malignancies in women with cervical cancer: A population-based study in Taiwan over a 30-year period. Gynecologic Oncology 2012;127:625-30. [DOI: 10.1016/j.ygyno.2012.09.004] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 1.6] [Reference Citation Analysis]
Number Citing Articles
1 Samerdokiene V, Valuckas KP, Janulionis E, Atkocius V, Rivard MJ. Second primary malignancies after radiotherapy including HDR (252)Cf brachytherapy for cervical cancer. Brachytherapy 2015;14:898-904. [PMID: 26194049 DOI: 10.1016/j.brachy.2015.06.006] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.9] [Reference Citation Analysis]
2 Nikolaidis C, Nena E, Panagopoulou M, Balgkouranidou I, Karaglani M, Chatzaki E, Agorastos T, Constantinidis TC. PAX1 methylation as an auxiliary biomarker for cervical cancer screening: a meta-analysis. Cancer Epidemiol 2015;39:682-6. [PMID: 26234429 DOI: 10.1016/j.canep.2015.07.008] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 1.6] [Reference Citation Analysis]
3 Gilbert DC, Wakeham K, Langley RE, Vale CL. Increased risk of second cancers at sites associated with HPV after a prior HPV-associated malignancy, a systematic review and meta-analysis. Br J Cancer 2019;120:256-68. [PMID: 30482913 DOI: 10.1038/s41416-018-0273-9] [Cited by in Crossref: 28] [Cited by in F6Publishing: 20] [Article Influence: 7.0] [Reference Citation Analysis]
4 Suk R, Mahale P, Sonawane K, Sikora AG, Chhatwal J, Schmeler KM, Sigel K, Cantor SB, Chiao EY, Deshmukh AA. Trends in Risks for Second Primary Cancers Associated With Index Human Papillomavirus-Associated Cancers. JAMA Netw Open 2018;1:e181999. [PMID: 30646145 DOI: 10.1001/jamanetworkopen.2018.1999] [Cited by in Crossref: 28] [Cited by in F6Publishing: 17] [Article Influence: 7.0] [Reference Citation Analysis]
5 Li R, Zhang Y, Ma B, Tan K, Lynn HS, Wu Z. Survival analysis of second primary malignancies after cervical cancer using a competing risk model: implications for prevention and surveillance. Ann Transl Med 2021;9:239. [PMID: 33708866 DOI: 10.21037/atm-20-2003] [Reference Citation Analysis]
6 Neumann F, Jégu J, Mougin C, Prétet JL, Guizard AV, Lapôtre-Ledoux B, Bara S, Bouvier V, Colonna M, Troussard X, Trétarre B, Grosclaude P, Velten M, Woronoff AS. Risk of second primary cancer after a first potentially-human papillomavirus-related cancer: A population-based study. Prev Med 2016;90:52-8. [PMID: 27370167 DOI: 10.1016/j.ypmed.2016.06.041] [Cited by in Crossref: 27] [Cited by in F6Publishing: 22] [Article Influence: 4.5] [Reference Citation Analysis]
7 Adjei Boakye E, Grubb L, Peterson CE, Osazuwa-Peters N, Grabosch S, Ladage HD, Huh WK. Risk of second primary cancers among survivors of gynecological cancers. Gynecol Oncol 2020;158:719-26. [PMID: 32616403 DOI: 10.1016/j.ygyno.2020.06.492] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
8 Lim MC, Won YJ, Lim J, Kim YJ, Seo SS, Kang S, Lee ES, Oh JH, Kim JY, Park SY. Second Primary Cancer after Diagnosis and Treatment of Cervical Cancer. Cancer Res Treat 2016;48:641-9. [PMID: 26194366 DOI: 10.4143/crt.2014.326] [Cited by in Crossref: 7] [Cited by in F6Publishing: 12] [Article Influence: 1.0] [Reference Citation Analysis]
9 Hung H, You J, Chiang J, Hsieh P, Chiang S, Lai C, Tasi W, Yeh C, Chern Y, Hsu Y. Clinicopathological characteristics and outcomes of metachronous rectal cancer in patients with a history of cervical cancer with and without remote radiotherapy: Reports of 45 cases. Medicine (Baltimore) 2020;99:e21328. [PMID: 32791729 DOI: 10.1097/MD.0000000000021328] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
10 Chen MF, Yang YH, Lai CH, Chen PC, Chen WC. Outcome of patients with esophageal cancer: a nationwide analysis. Ann Surg Oncol. 2013;20:3023-3030. [PMID: 23525703 DOI: 10.1245/s10434-013-2935-4] [Cited by in Crossref: 48] [Cited by in F6Publishing: 51] [Article Influence: 5.3] [Reference Citation Analysis]
11 Everhov ÅH, Ekberg S, Hirschberg AL, Bergmark K, Rådestad AF, Glimelius I, Smedby KE. Lost workdays in uterine cervical cancer survivors compared to the general population: impact of treatment and relapse. J Cancer Surviv 2016;10:514-23. [DOI: 10.1007/s11764-015-0496-1] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
12 Teng CJ, Huon LK, Hu YW, Yeh CM, Chao Y, Yang MH, Chen TJ, Hung YP, Liu CJ. Secondary Primary Malignancy Risk in Patients With Cervical Cancer in Taiwan: A Nationwide Population-Based Study. Medicine (Baltimore) 2015;94:e1803. [PMID: 26512575 DOI: 10.1097/MD.0000000000001803] [Cited by in Crossref: 20] [Cited by in F6Publishing: 14] [Article Influence: 3.3] [Reference Citation Analysis]
13 Janulionis E, Samerdokiene V, Valuckas KP, Atkocius V, Rivard MJ. Second primary malignancies after high-dose-rate 60Co photon or 252Cf neutron brachytherapy in conjunction with external-beam radiotherapy for endometrial cancer. Brachytherapy 2018;17:768-74. [DOI: 10.1016/j.brachy.2018.05.004] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
14 Dost F, Ford PJ, Farah CS. Heightened risk of second primary carcinoma of the head and neck following cervical neoplasia: Head and neck cancer following cervical cancer. Head Neck 2014;36:1132-7. [DOI: 10.1002/hed.23417] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
15 Wen CT, Fu JY, Wu CF, Hsieh MJ, Liu YH, Wu YC, Tsai YH, Wu CY. Survival impact of locoregional metachronous malignancy in survival of lung cancer patients who received curative treatment. J Thorac Dis 2016;8:1139-48. [PMID: 27293830 DOI: 10.21037/jtd.2016.04.45] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
16 Liao SC, Yeh HZ, Chang CS, Chen WC, Muo CH, Sung FC. Colorectal Cancer Risk in Women with Gynecologic Cancers-A Population Retrospective Cohort Study. J Clin Med 2021;10:3127. [PMID: 34300293 DOI: 10.3390/jcm10143127] [Reference Citation Analysis]